References
- FITZGERALD JD, SINGH BN: Effects of beta blockers oncardiovascular morbidity and mortality in coronary artery disease. In: Cardiovascular Pharmacology and Therapeutics. Sigh BN, Dzau BJ, VanHoutte PM, Woolsley RL (Eds) Churchill Livingstone (1994), New York, London: 511–514.
- THE EPIC INVESTIGATORS: Use of a monoclonal anti-body directed against platelet glycoprotein llb-Ela re-ceptor in high risk coronary angioplasty. N. Engl.J. Med. (1994) 330:956–961.
- PACKER M: Vasodilator and inotropic drugs for the treatment of chronic heart failure Distinguishing hype from hope. J. Am. Coll. Card to!. (1988) 12:1299.
- KANE JP, MALLOY MJ, PORTS TA, ET AL.: Regression of coronary atherosclerosis during treatment of familial hypercholesterolaemia with combined drug regimes. JAMA (1990) 264:307.
- DAVIES MJ, THOMAS AC: Plaque fissuring: The cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br. Heart J. (1985) 53:363–373.
- VAN DER WAL AC, BECKER AE, VAN DE LOOS CM, DAS PK: Site of internal rupture of erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 89:36–44.
- HENNEY AM, WAKELEY PR, DAVIES ME, ET AL.: Localiza-tion of stromeiysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA (1991) 88:8154–8158.